Login / Register The Most Trusted Name in Medical Education


Improve your rheumatology knowledge by taking one of Elsevier's complimentary continuing medical education courses.

910654 116 x 140

Updates in Improving Care of Patients With Rheumatoid Arthritis

Format: Interactive Monograph

Rheumatoid arthritis (RA) remains a clinically-challenging autoimmune disorder for rheumatologists to manage. Effective patient care is critical: an estimated sixty percent of people with inadequately-treated RA are unable to work 10 years following onset of the disease. The American College of Rheumatology (ACR) has endorsed the use of several quality improvement measures in RA management, including recommended screening, disease activity assessment, and treatment guidelines. However, clinical care of patients with respect to guideline recommendations continue to be suboptimal. 

Take Course »

Credits: 1.75 AMA PRA Category 1 Credit(s)™
RA 800x275 Combe

Clinical Advances in Rheumatoid Arthritis Resource Center

Format: Resource Center

The Global Learning Center provides you with free access to the latest peer-reviewed clinical information related to the treatment of patients with rheumatoid arthritis (RA). The RA Global Learning Center is a freely accessible platform that aims to increase clinical knowledge by providing continuing medical educational (CME) activities, research articles, and other resources to healthcare providers who treat patients with RA. 

Go to Resource Center »

910622 116 x 140

An Update on Osteoporosis Pathogenesis, Diagnosis, and Treatment

Format: Webcast

An Update on Osteoporosis Pathogenesis, Diagnosis, and Treatment is an on-demand webcast CME activity.  Osteoporosis is a serious health problem that is increasing with the growth of the aging population. Left untreated, patients with osteoporosis experience considerable morbidity and increased mortality, and their care exacts a large economic burden on the health care system. Although regularly updated clinical guidelines, risk assessment tools, and effective pharmacologic agents are available for the prevention and treatment of osteoporosis, data indicate that patients are not receiving the recommended level of care. In fact, the percentage of patients receiving osteoporosis treatment has declined in recent years even in those with hip fractures.

Register »

Credits: 1.00 AMA PRA Category 1 Credit(s)™